Mariam G. Polito
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Artificial intelligence for bone metastases: a systematic review and meta-analysis of diagnostic and prognostic performance.
Journal: Frontiers in oncology
Published: June 22, 2026
Skeletal metastatic burden as a strong prognostic factor of survival in advanced NSCLC treated with chemo-immunotherapy: An exploratory imaging-based analysis.
Journal: Journal of bone oncology
Published: June 18, 2026
Impact of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy on pCR and Tumor Downstaging in Resectable Gastric Cancer: A Meta-Analysis.
Journal: Cancers
Published: May 30, 2026
Artificial intelligence-enabled liquid biopsy in cancer: a systematic review and meta- analysis of diagnostic performance and biological implications.
Journal: Frontiers in oncology
Published: April 08, 2026
Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
Journal: Cancer diagnosis & prognosis
Published: February 18, 2026
Complete response in metastatic clear cell renal cell carcinoma following pembrolizumab-axitinib and subsequent nephrectomy: a Case Report.
Journal: Frontiers in immunology
Published: February 14, 2026
Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis.
Journal: Breast cancer research and treatment
Published: November 07, 2025
Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting.
Journal: Targeted oncology
Published: June 03, 2025
The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 30, 2025
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population.
Journal: International journal of cancer
Published: January 29, 2025
Last Updated: 09/26/2026